Tabrez, S., Khan, A. U., Hoque, M., Suhail, M., Khan, M. I., & Zughaibi, T. A. (2022). Investigating the anticancer efficacy of biogenic synthesized MgONPs: An in vitro analysis. Frontiers in Chemistry, 10, 970193.
Article CAS PubMed PubMed Central Google Scholar
Alafaleq, N. O., Zughaibi, T. A., Jabir, N. R., Khan, A. U., Khan, M. S., & Tabrez, S. (2023). Biogenic Synthesis of Cu-Mn Bimetallic Nanoparticles Using Pumpkin Seeds Extract and Their Characterization and Anticancer Efficacy. Nanomaterials (Basel, Switzerland), 13, 7.
Ahmad, I., Hoque, M., Alam, S. S. M., Zughaibi, T. A., & Tabrez, S. (2023). Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment. International Journal of Molecular Sciences, 24(7), 6651.
Article CAS PubMed PubMed Central Google Scholar
Hanahan, D., & Coussens, L. M. (2012). Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell, 21(3), 309–322.
Article CAS PubMed Google Scholar
Ebos, J. M., & Kerbel, R. S. (2011). Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nature reviews Clinical oncology, 8(4), 210–221.
Article CAS PubMed PubMed Central Google Scholar
Segovia-Mendoza, M., & Morales-Montor, J. (2019). Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology. Frontiers in immunology, 10, 348.
Article CAS PubMed PubMed Central Google Scholar
Anderson, N. M., & Simon, M. C. (2020). The tumor microenvironment. Current Biology, 30(16), R921–r5.
Article CAS PubMed Google Scholar
Peña-Romero, A. C., & Orenes-Piñero, E. (2022). Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. Cancers, 14, 7.
Ma, Y., Shurin, G. V., Peiyuan, Z., & Shurin, M. R. (2013). Dendritic cells in the cancer microenvironment. Journal of Cancer, 4(1), 36–44.
Article CAS PubMed Google Scholar
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012). The tumor microenvironment at a glance. Journal of cell science, 125(Pt 23), 5591–5596.
Article CAS PubMed Google Scholar
Barzegari, A., Saeedi, N., Zarredar, H., Barar, J., & Omidi, Y. (2014). The search for a promising cell factory system for production of edible vaccine. Human Vaccines & Immunotherapeutics, 10(8), 2497–2502.
de Looff, M., de Jong, S., & Kruyt, F. A. E. (2019). Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy. Frontiers in immunology, 10, 1530.
Article PubMed PubMed Central Google Scholar
Ma, C., Luo, H., Cao, J., Zheng, X., Zhang, J., & Zhang, Y., et al. (2020). Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma. Frontiers in molecular biosciences, 7, 571641.
Article CAS PubMed PubMed Central Google Scholar
Xiao, B., Peng, J., Wang, Y., Deng, Y., Ou, Q., & Wu, X., et al. (2020). Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis. Annals of translational medicine, 8(19), 1221.
Article CAS PubMed PubMed Central Google Scholar
Maimela, N. R., Liu, S., & Zhang, Y. (2019). Fates of CD8+ T cells in Tumor Microenvironment. Computational and structural biotechnology journal, 17, 1–13.
Article CAS PubMed Google Scholar
Ohue, Y., & Nishikawa, H. (2019). Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer science, 110(7), 2080–2089.
Article CAS PubMed PubMed Central Google Scholar
Fridman, W. H., Meylan, M., Petitprez, F., Sun, C. M., Italiano, A., & Sautès-Fridman, C. (2022). B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nature reviews Clinical oncology, 19(7), 441–457.
Article CAS PubMed Google Scholar
Boutilier, A. J., & Elsawa, S. F. (2021). Macrophage Polarization States in the Tumor Microenvironment. International Journal of Molecular Science, 22, 13.
Poh, A. R., & Ernst, M. (2018). Targeting Macrophages in Cancer: From Bench to Bedside. Frontiers in Oncology, 8, 49.
Article PubMed PubMed Central Google Scholar
Masucci, M. T., Minopoli, M., & Carriero, M. V. (2019). Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy. Frontiers in Oncology, 9, 1146.
Article PubMed PubMed Central Google Scholar
Tabrez, S., Khan, A. U., Mirza, A. A., Suhail, M., Jabir, N. R., & Zughaibi, T. A., et al. (2022). Biosynthesis of copper oxide nanoparticles and its therapeutic efficacy against colon cancer. Nanotechnology Reviews, 11(1), 1322–1331.
Prete, A. D., Salvi, V., Soriani, A., Laffranchi, M., Sozio, F. & Bosisio, D. et al. (2023). Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cellular & molecular immunology, 20(5), 432–447.
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D.F. & Merad, M. (2018). Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine, 24(5), 541–550.
Article CAS PubMed PubMed Central Google Scholar
Yu, Y. R., & Ho, P. C. (2019). Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting. Clinical and experimental immunology, 197(2), 153–160.
Article CAS PubMed Google Scholar
Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature medicine, 19(11), 1423–1437.
Article CAS PubMed PubMed Central Google Scholar
Kitamura, T., Qian, B. Z., & Pollard, J. W. (2015). Immune cell promotion of metastasis. Nature reviews Immunology, 15(2), 73–86.
Article CAS PubMed PubMed Central Google Scholar
Chaudhary, B., & Elkord, E. (2016). Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines., 4, 3.
Laviron, M., & Boissonnas, A. (2019). Ontogeny of Tumor-Associated Macrophages. Frontiers in immunology, 10, 1799.
Article CAS PubMed PubMed Central Google Scholar
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008). The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Critical reviews in oncology/hematology, 66(1), 1–9.
Gowd, V., Ahmad, A., Tarique, M., Suhail, M., Zughaibi, T. A., & Tabrez, S., et al. (2022). Advancement of cancer immunotherapy using nanoparticles-based nanomedicine. Seminars in cancer biology, 86(Pt 2), 624–644.
Article CAS PubMed Google Scholar
Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., & Tessitore, A., et al. (2013). The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. BioMed research international, 2013, 187204.
Wang, J., Li, D., Cang, H., & Guo, B. (2019). Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Cancer medicine, 8(10), 4709–4721.
Article PubMed PubMed Central Google Scholar
Xu, L., Zou, C., Zhang, S., Chu, T. S. M., Zhang, Y., & Chen, W., et al. (2022). Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. Journal of hematology & oncology, 15(1), 1–30.
Kim, H. J., Ji, Y. R., & Lee, Y. M. (2022). Crosstalk between angiogenesis and immune regulation in the tumor microenvironment. Archives of Pharmacal Research, 45(6), 401–416.
Article CAS PubMed PubMed Central Google Scholar
Groner, B., & von Manstein, V. (2017). Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition. Molecular and cellular endocrinology, 451, 1–14.
Article CAS PubMed Google Scholar
Mimura, K., Teh, J. L., Okayama, H., Shiraishi, K., Kua, L. F., & Koh, V., et al. (2018). PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer science, 109(1), 43–53.
Article CAS PubMed Google Scholar
Abaza, A., Idris, F. S., Shaikh, H. A., Vahora, I., Moparthi, K. P., & Al Rushaidi, M. T., et al. (2023). Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics. Cureus., 15, 9.
留言 (0)